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ARTICLE
Local enrichment of HP1alpha at telomeres alters
their structure and regulation of telomere
protection
Tracy T. Chow 1, Xiaoyu Shi 2, Jen-Hsuan Wei1,3, Juan Guan2, Guido Stadler4, Bo Huang 2,5 &
Elizabeth H. Blackburn 1,6
Enhanced telomere maintenance is evident in malignant cancers. While telomeres are
thought to be inherently heterochromatic, detailed mechanisms of how epigenetic
modifications impact telomere protection and structures are largely unknown in human
cancers. Here we develop a molecular tethering approach to experimentally enrich hetero-
chromatin protein HP1α specifically at telomeres. This results in increased deposition
of H3K9me3 at cancer cell telomeres. Telomere extension by telomerase is attenuated,
and damage-induced foci at telomeres are reduced, indicating augmentation of telomere
stability. Super-resolution STORM imaging shows an unexpected increase in irregularity
of telomeric structure. Telomere-tethered chromo shadow domain (CSD) mutant I165A of
HP1α abrogates both the inhibition of telomere extension and the irregularity of telomeric
structure, suggesting the involvement of at least one HP1α-ligand in mediating these effects.
This work presents an approach to specifically manipulate the epigenetic status locally
at telomeres to uncover insights into molecular mechanisms underlying telomere structural
dynamics.
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Telomere maintenance is indispensable for indefinite pro-liferation of cancer cells. Mammalian telomeres consist oftracts of hexameric DNA repeats (5′-TTAGGG-3′) bound
by protective nonhistone proteins in a complex called shelterin1,2.
Paradoxically, in spite of the nucleosome-disfavoring properties
of telomeric repeats3, mammalian telomeric DNA is also orga-
nized into closely packed nucleosomes4. It is unknown how the
resulting telomeric chromatin domain, consisting of the telomere
nucleosomal chromatin plus shelterin complex, establishes a
capping structure to maintain genome integrity5,6. While func-
tions associated with shelterin itself have been widely studied,
molecular details of how this peculiar telomere chromatin
impacts mammalian telomere maintenance remain largely
unexplored.
Telomere chromatin is thought to be inherently condensed
heterochromatin primarily based on findings in yeast7,8, Droso-
phila9, and mouse10. In these organisms, establishment of telo-
meric and subtelomeric heterochromatin is crucial for
chromosomal end protection5. However, recent studies suggest
that human and Arabidopsis telomere chromatins are relatively
dynamic, characterized by a mix of heterochromatic and
euchromatic marks, as well as enrichments of histone modifica-
tions associated with active transcription11–14. Besides canonical
telomere capping, telomeric chromatin also regulates telomere
position effect (TPE)15, telomere transcription16, homologous
recombination at telomeres17,18, cellular differentiation19, and
nuclear reprogramming20.
Roles for epigenetic regulation of telomere maintenance have
been sought in many studies. Knockout of various histone
modifying enzymes such as histone methyltransferases
SUV39H1/2, SUV4-20H1/210,17,21 result in defective telomere
function, aberrantly increased telomere length, and chromosomal
instability. Depletion of yeast histone methyltransferase Dot122
and its homolog in mouse (Dot1L)23, mammalian histone
modifier ATRX and its chaperon DAXX24,25, yeast histone dea-
cetylases Sir226 and its orthologs in mouse (Sirt1)27 and human
(Sirt6)28 result in a range of altered or defective telomere main-
tenance phenotypes. These include alterations in telomere
length10,21, recombination which characterizes alternative telo-
mere lengthening10,17,29, TPE15, telomere transcription25, DNA
damage at the telomeres27, or increased telomere fusion and
premature senescence28. However, in such knockout or knock-
down studies, it is very difficult to interpret the molecular
mechanisms underlying the dynamics of telomeric chromatin
because they take place in settings of global genomic changes in
chromatin and histone modifying enzymes. Therefore, we desired
to set up an alternative approach to engineer localized manip-
ulations of telomere chromatin.
A common feature of heterochromatin-mediated telomere
protection in Drosophila and yeast is that their telomeric and
subtelomeric chromatins respectively are enriched in hetero-
chromatin marks such as trimethylation of lysine 9 of histone H3
(H3K9me3)30. H3K9me3 provides a high affinity binding site for
HP1 (heterochromatin protein 1), and recruits histone methyl-
transferase SUV39H to catalyze the propagation of this mark to
establish heterochromatin31. Extensive studies of hetero-
chromatin marks, using chromatin immunoprecipitation (ChIP)
and genome-wide chromatin state mapping, have reported
enrichment of H3K9me3 and other heterochromatin marks in
mouse subtelomere and telomeres30. In striking contrast to this
reported high H3K9me3 at mouse telomeres, unexpectedly low
density of telomere H3K9me3 and rather infrequent HP1 are
naturally localized at human telomeres11,14,32–35. This provides
an opportunity to enhance the presence of this naturally
occurring component of telomeric chromatin to study its role in
telomere biology.
In this report, we present an approach to study the con-
sequences of locally altering telomere chromatin properties on the
key functions of telomeres. We enrich heterochromatinization at
telomeres by fusing HP1alpha (HP1α) to the telomere binding
shelterin protein TRF1. We find that deposition of hetero-
chromatin marks at telomeres is increased and telomerase-
mediated telomere extension is attenuated. Mutational studies of
such telomere-tethered HP1α show the chromo shadow domain
(CSD) of the telomere-tethered HP1α is involved in attenuating
telomere extension. Additionally, DNA-damage responses at
telomeres, triggered by either expressing mutant-template telo-
merase RNA (hTR) or depletion of shelterin TRF2, are reduced,
suggesting enhanced telomere stability. Direct super-resolution
visualization of this HP1α-tethered telomere chromatin in cells by
stochastic optical reconstruction microscopy (STORM) imaging
shows previously unsuspected less globular, more irregularly
shaped telomere structures. These findings provide a platform for
understanding the crosstalk between altered chromatin environ-
ment, epigenetic regulation and telomere maintenance.
Results
A model system to study HP1α function at telomeres. To
study how altered telomere chromatin regulates its
maintenance, we set up a controlled system to enhance hetero-
chromatin in a locus-specific manner. We fused shelterin TRF1,
which confers telomeric locus-specificity, to HP1α, a protein
involved in heterochromatin establishment and maintenance.
HP1α contains a conserved N-terminal chromo domain (CD)
that binds to dimethylated and trimethylated H3K9 (H3K9me2/
3) and a C-terminal CSD for dimerization and ligand
binding31,36. These two domains are joined by a flexible hinge
domain (Fig. 1a)31.
To validate our system, EGFP-tagged TRF1 fused with HP1α
(Fig. 1a) was transiently cotransfected with mCherry-tagged
TRF2, a core shelterin component, and tested for colocalization at
telomeres (Fig. 1b) in human bladder cancer UM-UC3 cells. As
expected, EGFP-HP1α is capable of localizing to nontelomeric
genomic regions, resulting in a significantly higher total average
HP1α occupancy (~16.7% area per nucleus) compared to EGFP-
TRF1 (~5.0%) that localized exclusively to telomeres (Fig. 1c), as
measured by percent EGFP per nucleus. Meanwhile, TRF1HP1α
also localized to genomic regions other than telomeres with no
significant difference of average nucleus occupancy (~17.3%)
compared to control HP1α (~16.7%). Thus, TRF1HP1α also
retained the functional abilities of HP1α for targeting and
chromatin spreading (Fig. 1c). A point mutation in the CD
domain of the TRF1HP1α-fusion construct (V22M), which
abrogates recognition of H3K9me3 by HP1α, maintained its
ability to localize at telomeres, as will be discussed further below,
and reverted average EGFP occupancy in the nucleus to ~6.4%.
Average colocalization with TRF2 was significantly higher for
both EGFP-TRF1HP1α (~74.2%) and EGFP-TRF1 (~62.1%)
compared to EGFP-HP1α alone (~46.9%) (Fig. 1d). Thus,
TRF1HP1α is expressed and specifically enriched at telomeres.
TRF1HP1α expression increases H3K9me3 per H3 at telo-
meres. In addition to microscopy, we also used ChIP to follow the
genomic localization of stably expressed TRF1HP1α cells
(Fig. 1e–j). Immunoprecipitated chromatin was hybridized with
either telomeric or control centromeric (CENPB) probe (Fig. 1f).
After normalizing to intensity of 10% total chromatin input,
TRF1HP1α showed ~28-fold increased average HP1α at telo-
meres compared to controls (Fig. 1f, g). While TRF1 over-
expression resulted in a slight decrease of H3 at telomeres
compared to vector only (Vonly) or HP1α, each of the three
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control groups showed higher H3 compared to TRF1HP1α
(Fig. 1f, h). Combining all three control groups, TRF1HP1α
showed less H3 (~0.7 fold) per telomere (Fig. 1f, h). We then
asked if H3K9me3 heterochromatin marks at telomeres were
increased. Upon normalizing to telomeric H3, TRF1HP1α
showed a small but significant (~1.5-fold) increase of H3K9me3
at telomeres. (Fig. 1f, i). Meanwhile, there was no significant
change in TRF2 occupancy, a core component of shelterin
complex (Fig. 1f, j). Moreover, TRF1HP1α by itself did not induce
DNA damage at telomeres, as will be discussed in detail below,
suggesting shelterin integrity remained intact. See Supplementary
Fig. 1 for independent, uncropped images of triplicate ChIP
experiments. In summary, we established a controlled system to
alter telomere heterochromatin by HP1α tethering, resulting in
increased H3K9me3 at telomeres.
TRF1HP1α attenuates telomere extension. To investigate if
tethered HP1α-induced heterochromatin regulates telomere
extension by telomerase, EGFP-tagged TRF1HP1α or corre-
sponding control groups (Vonly, TRF1, HP1α) were introduced
into UM-UC3 cells via lentiviral construct infection. Blasticidin-
selected cells were FACS sorted for medium EGFP expression
(assigned as Population Doubling PD0). Protein expression was
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Fig. 1 Tethered HP1α at telomeres locally increases H3K9me3. a Schematic of HP1α fused to TRF1. HP1α consists of a chromo domain (CD), a hinge, and a
chromo shadow domain (CSD); AA (amino acid). b−d Fluorescence imaging of UM-UC3 cells cotransfected with mCherry-tagged TRF2 and EGFP-TRF1,
EGFP-HP1α, or EGFP-TRF1HP1α-fusion 48 h after transfection (n= 15–21 nuclei). b Representative images. mCherry shown as magenta in merged image.
Scale bar: 10 µm. c Quantification of % EGFP area per nucleus ****p < 0.0001; n.s. (no significance). d Quantification of % telomere per nucleus with
colocalization of EGFP and TRF2 (mCherry) **p= 0.0065; ****p < 0.0001. The high apparent colocalization of HP1α with TRF2 (within the HP1α group) is
partly caused by random, coincidental overlaps with telomeres due to widespread HP1α spots; X−Y planes are projections of z-stacks. c, d Significance
is assessed by one-way ANOVA and Dunnett’s multiple comparison test with 95% confidence level. Error bars represent standard error of the mean
(s.e.m.). e Experimental set-up for ChIP to follow the localization of stably expressed TRF1HP1α in UM-UC3 after blasticidin selection (Bsd) at ~PD25.
f Experimental groups are immunoprecipitated with the indicated antibodies, and hybridized on a dot blot with either telomere or control centromere
(CENPB) probe (n= 3 independent replicates). Upon signal normalization to 10% input, g TRF1HP1α shows increased HP1α at telomeres compared to
controls Vector only (Vonly), TRF1 and HP1α ****p < 0.0001; h TRF1HP1α shows decreased H3 at telomeres *p= 0.0133. Upon normalization to H3 signal,
i TRF1HP1α shows increased H3K9me3 at telomeres per H3 *p= 0.0101 while j there is no significant change of TRF2 occupancy at telomeres. n.s.
(no significance) g−j The values for three independent experiments (Supplementary Fig. 1) are used to calculate the s.e.m. for each group. p values
are calculated by two-tailed unpaired t test with 95% confidence level
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validated by western blot analysis (Supplementary Fig. 2). All
overexpression cell lines showed only minimal alteration in tel-
omere length up to ~PD80 (Supplementary Fig. 3). This obser-
vation is consistent with a previous report that only long-term
culturing of TRF1 overexpression in certain cancer cells resulted
in telomere shortening37. To better resolve changes in length,
telomere extension was enhanced by overexpressing WT hTR
(template specifying 5′-TTAGGG-3′ repeats), which we have
previously shown lengthens telomeres in UM-UC3 cells during
the following few days in culture38. WT hTR was introduced via a
second round of infection with the experimental set-up dia-
grammed in Fig. 2a. Southern blotting (Telomere Restriction
Fragment Length) analysis showed that the telomere-tethered
TRF1HP1α expression attenuated telomere extension compared
to Vonly, TRF1-alone, or HP1α-alone controls (Fig. 2b, c).
Uncapped telomeres elicit senescence in cultured human
fibroblasts. We used the senescence-associated beta-galactosidase
(β-gal) assay to determine if TRF1HP1α influenced replicative
senescence. High PD normal human foreskin fibroblast BJ cells
showed the expected increase of β-gal fluorescence units (~2.6-
fold higher than at lower PD; Fig. 2d, e). However, in two primary
fibroblast cell lines, BJ or WI-38, there were no significant
differences among TRF1HP1α or corresponding Vonly or TRF1
control groups (Fig. 2f–h). Thus, tethered HP1α at telomeres did
not exacerbate replicative senescence in fibroblasts, further
validating the intact functionality of the manipulated telomeric
chromatin domain.
Tethering TRF1HP1α containing mutations within HP1α. To
rule out potential indirect effects due to tethering of TRF1HP1α
to nontelomeric HP1α genomic loci and to understand
mechanistically how HP1α inhibited telomere elongation, HP1α
constructs carrying various characterized separation-of-function
mutations fused with TRF1, as above, were introduced into UM-
UC3 cells (Fig. 3a): (i) CD mutant V22M39, defective in recog-
nizing H3K9me3 marks; CSD mutants (ii) I165A39, deficient in
dimerization and ligand binding and (iii) W174A39, which can
dimerize but is deficient in ligand binding; (iv) N-terminal
phosphorylation mutant NS2A40, to perturb oligomerization; and
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Fig. 2 Telomere-tethered HP1α attenuates telomere extension by telomerase but does not accelerate replicative senescence. a Experimental set-up to
study the impact of HP1α on telomerase-based telomere extension in UM-UC3. First infection: EGFP-tagged Vonly, TRF1, HP1α, or TRF1HP1α. b Telomere
length analysis of TRF1HP1α, various controls, and untreated parental cells (Prn) with WT hTR overexpression from PD0 to ~PD30. c Quantification
(average telomere length) shows TRF1HP1α attenuates the WT hTR overexpression-induced telomere extension. Similar findings are observed in two
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fluorescence units are normalized to µg of protein. BJ PD68 shows significantly more β-gal fluorescence than BJ PD34 ****p < 0.0001. Two independent
experiments; each contains triplicates. Error bars represent s.e.m. p values are calculated by two-tailed unpaired t test with 95% confidence level.
f Experimental set-up to determine if TRF1HP1α accelerates replicative senescence. These analyses were performed only 10–12 days after infection,
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(v) hinge mutant KRKAAA36,41, deficient in HP1α DNA / RNA
interaction (Fig. 3a).
Validation of the ability of these mutant proteins to localize to
telomeres or other genomic regions was performed as described
for Fig. 1b–d. WT TRF1HP1α and all mutants tested had
considerable amounts of tethering to other genomic regions
except for V22M or V22MI165A (which do not recognize
H3K9me3) (Fig. 3b). Average HP1α nucleus occupancy was
reduced in V22M (~6.4%) and the double mutant V22MI165A
(~6.3%), but not I165A (~27.1%), compared to WT TRF1HP1α
(~22.5%) (Fig. 3b, c). Consistent patterns were observed by
quantifying total numbers of fusion protein spots per nucleus
(Supplementary Fig. 4). Thus, loss of H3K9me3 binding by V22M
or V22MI165A resulted in deficient anchorage to nontelomeric
chromatin.
However, all mutants, including V22M and V22MI165A,
were efficiently tethered at the telomeres via their fused TRF1
(~67.1–83.4% colocalization; Fig. 3b, d). Thus, in this controlled
tethering system, telomere anchorage of V22M was efficiently
driven by its TRF1 fusion and did not require HP1α recognition
of H3K9me2/3, that might potentially have contributed to
nontelomeric localization. Therefore, we deliberately used
V22M to control for possible indirect effects due to tethering
of TRF1 to nontelomeric HP1α genomic sites. Meanwhile,
there was no significant change in number of TRF2 foci per
nucleus (Fig. 3e).
Chromo shadow domain of HP1α attenuates telomere exten-
sion. To determine which domain functions of HP1α control
telomere extension by telomerase, we generated cells stably
overexpressing TRF1HP1α-constructs harboring various muta-
tions within HP1α (Fig. 3a–d), using the experimental set-up
shown (Fig. 2a). Interestingly, WT TRF1HP1α and V22M limited
telomere extension to similar extents (Fig. 3f, h). Hence, because
TRF1 tethering of HP1α to telomeres bypassed the need for
H3K9me2/3 recognition for HP1α recruitment to telomeres,
HP1α recognition of H3K9me2/3 per se was not required for this
inhibition of telomere extension. In contrast, I165A abolished
the inhibition of telomere lengthening, as did V22MI165A
(Fig. 3f, h). Since I165A abrogates both dimerization and ligand
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Fig. 3 Ligand binding function of HP1α CSD controls telomere extension. a Schematic diagram of mutations in HP1α fused to TRF1 (AA—amino acid). CD
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binding, we sought to separate which function was primary in
this regulation of telomerase action. An additional CSD mutant
W174A, which is deficient in ligand binding but can still
dimerize, only partially restored the inhibition of lengthening rate
(Fig. 3g, i). Thus, because dimerization was not sufficient to fully
inhibit telomerase action down to the WT TRF1HP1α level, the
ligand binding (and possibly also dimerization) function of CSD
is required to inhibit telomere extension. Finally, N-terminal
phosphorylation and the hinge DNA-binding domain were not
required to inhibit telomere extension (mutants NS2A and
KRKAAA in Fig. 3g, i).
TRF1HP1α reduces telomere damage induced by mutant hTR.
Knowing that TRF1HP1α inhibited telomere extension
(Figs. 2, 3), using an independent readout for telomerase func-
tion, we determined whether TRF1HP1α-induced inhibition of
telomerase would lead to less incorporation of mutant
hTR-specified telomeric DNA, and hence lead to a diminished
DNA-damage response at telomeres. Incorporated mutant telo-
mere repeats cannot bind shelterin proteins, and lead to rapid
uncapping and localized telomere damage foci42. Cells were
infected on day 0 with WT hTR or mutant hTRs, either 47A (5′-
TTTGGG-3')38 or TSQ1 (5′-GTTGCG-3')43, and selected for
stable expression after 48 h. On day 5, 53BP1 DNA-damage foci
present at telomeres, also referred to as telomere dysfunction-
induced foci (TIFs), were increased (Fig. 4a–c) compared to WT
hTR (Fig. 4d, e). We tested TIF induction early, when cell growth
was only mildly affected (Supplementary Fig. 5). Introduction of
TRF1HP1α yielded fewer average 47A-induced TIFs (~13.4%)
compared to controls Vonly (~23.8%), TRF1 (~28.6%) and HP1α
(~23.8%) (Fig. 4a, b). Similar findings were also observed with
TSQ1 treatment (Fig. 4c). Moreover, WT TRF1HP1α (~13.4%)
and V22M (~16.7%) showed similar TIFs (Fig. 4a, b). However,
elevated TIFs were observed in CSD mutants I165A (~27.7%),
W174A (~22.6%), and V22MI165A (~26.8%). In cells over-
expressing WT hTR, minimal baseline DNA damage at telomeres
was observed in corresponding controls (ranging from 4.1–7.5%;
Fig. 4d, e) or Vonly (5.8–8.9%; Fig. 4f).
In these experiments, the DNA damage caused by incorporated
mutant repeats depends on telomerase action at telomeres. We
showed that WT TRF1HP1α inhibited telomere extension to
similar extents as mutants V22M, NS2A, and KRKAAA (Fig. 3).
If reduced TIF levels were solely due to telomerase inhibition, we
would expect that TIF induction upon 47A expression would be
similar with all four fusion proteins. However, notably, upon 47A
expression, NS2A and KRKAAA showed more TIFs compared to
WT and V22M TRF1HP1α (Fig. 4a, b). These results indicate a
separation of HP1α functions: on the one hand, in regulating
telomere extension via its C-terminal CSD (ligand binding and
dimerization) and on the other hand, in DNA-damage reduction
(via its N-terminal CD and hinge domains).
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Fig. 4 TRF1HP1α results in reduced TIFs induced by mutant hTR expression. Cells stably expressing TRF1HP1α (WT or mutant variants of HP1α) were
infected with lentivirus containing WT hTR, or mutant hTR (47A or TSQ1) on day 0, selected for stable expression after 48 h, and analyzed on day 5.
a Fluorescence microscopy images of representative cells expressing mutant hTR 47A stained with telomeric (Tel-Cy3) peptide nucleic acid (PNA) probes
(magenta in merged image) via fluorescent in situ hybridization (FISH), antibody against DNA-damage repair protein marker 53BP1 (green in merged
image), and counterstained with DAPI. Zoom-in images (the last row) correspond to yellow-squared regions of the row above. b % TIF per telomere
of each nucleus is quantified; n= 94–159 nuclei combining data of three independent experiments. ****p < 0.0001; n.s. (no significance). a, b Scale bar:
10 µm. c Upon TSQ1 expression, TRF1HP1α results in fewer TIFs compared to Vonly, TRF1 or HP1α controls. TRFHP1α ~11.4% shows decreased TIFs
compared to Vonly: ~19.7% ***p= 0.0008; TRF1: ~20.4% ***p= 0.0005; HP1α: ~17.9% *p= 0.0137 (n= 30–38 nuclei). b, c Significance is assessed
by one-way ANOVA and Dunnett’s multiple comparison test with 95% confidence level. d Fluorescence images of control cells overexpressing WT hTR
(n= 27–36 nuclei). Same color scheme as a. TIFs quantification in the presence of e WT hTR or f Vonly (n= 28–36 nuclei) show minimal baseline
DNA damage at telomeres. b, c; e, f Error bars represent s.e.m.
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Tethered HP1α reduces telomere damage induced by si-TRF2.
To further study the direct telomere-protective effect of HP1α, we
used two additional, independent approaches. First, we induced
telomere damage by efficiently knocking down TRF2 with
si-TRF2 (Fig. 5a). Baseline TIFs were quantified using control
non-targeting siRNA (Fig. 5b). TRF1HP1α mildly protected
from si-TRF2-induced telomere damage (Fig. 5c). Furthermore,
comparing across all of the TRF1HP1α mutants, the pattern of
allele-specific effects on TRF2-depletion-induced TIFs closely
paralleled their corresponding pattern on 47A-hTR-induced TIFs
(compare Fig. 4b with Fig. 5c). This similarity of protective
effects, against both telomerase-independent (TRF2 knockdown)
and telomerase-dependent (47A hTR-induced) damage, indicates
that in addition to its inhibitory effect on telomerase action,
telomere-tethered WT TRF1HP1α can also protect telomeres.
Independently, we also developed a CRISPR/Cas9-based
telomeric DNA-cutting strategy to induce telomere-specific
damage in cells (Supplementary Fig. 6). Interestingly, expressing
either TRF1 alone or telomere-tethered WT TRF1HP1α reduced
CRISPR-induced telomere DNA cutting to similar extent in
UM-UC3 cells. In summary, employing different approaches to
induce telomeric damage has uncovered different aspects of how
tethered HP1α affects telomere protection.
TRF1HP1α increases irregularly shaped telomere structures.
Telomere structures are smaller than the diffraction-limited
resolution (~250 nm) of conventional light microscopy44–46.
Under stochastic optical reconstruction microscopy (STORM),
the great majority of WT telomeres appear as spherical, globular
structures44–46. Using STORM, we examined whether HP1α
tethering altered the size or globular shape of telomeres. Under
our conditions, three-dimensional (3D) STORM provided XY
precision of ~30 nm and Z resolution of ~70 nm47. Cells stably
expressing TRF1HP1α, or corresponding control groups (TRF1,
HP1α), were collected for telomere length analysis or fixed for
STORM analysis. We first verified that all experimental groups,
collected at earliest passage after blasticidin selection (days 8–9
post lentiviral infection), showed similar population telomere
lengths (Fig. 6a). Therefore, any observed telomere shape changes
at the population level should not be a result of average telomere
length alteration.
3D STORM showed significantly better resolution compared to
conventional widefield imaging (Fig. 6b, top and middle panels).
The overlay image also allowed us to exclude any nontelomeric
background, ensuring the identified clusters correspond to
telomeres (Fig. 6b, bottom panel). To quantify structural changes
of individual telomeres, we measured the radius of gyration (Rg)
of each cluster. Rg represented the root-mean-square distance of
the localization points from the center of mass of a cluster
according to R2g ¼ ð1=NÞ
PN
k¼1ð r
*
k  r
*
centerofmassÞ2, where r
*
denotes position, k denotes the localization point index, and
N is the number of localization points. The average number of
localization points of such filtered individual telomeres for
TRF1, HP1α, WT TRF1HP1α, TRF1HP1αI165A were 664, 420,
544, and 639, respectively (Supplementary Fig. 7). As an imaging
quality control, we only analyzed telomere clusters with centers
of mass near the focal plane, and consisting of more than 200
localization points (Fig. 6c, bottom panel). Telomeric localization
points were clustered using Insight3 software47 to reconstruct
structures of individual telomeric foci (Fig. 6c, top panel). Across
all experimental groups, individual Rg values showed only weak
correlations with number of localization points (Supplementary
Fig. 7). Average Rg was similar in parental cells and Vonly,
suggesting any observable changes in Rg were not caused by the
vector itself (Supplementary Fig. 8).
Some generalities emerged from these analyses. As expected,
most telomeres appeared spherical, but heterogeneous shapes
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Fig. 5 TRF1HP1α allele-specific protection effects upon si-TRF2-induced telomeric damage. 72 h after transfection, a TRF2 knockdown efficiency with
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were also observed45. Figure 6c showed examples of individual
telomere structures across a gradient of Rg in TRF1HP1α.
Analyses showed telomeres with larger Rg displayed more
variable and irregular shapes; specifically, while more spread
out in three dimensions, they were compact (dense) in one
dimension (Fig. 6c). The distributions of Rg heterogeneity among
individual telomeres were consistently observed in multiple nuclei
for each experimental group (Fig. 6d–g). This indicated that the
observed structural differences among groups, as described below,
were unlikely to have been simply skewed by specific nuclei that
harbored Rg outliers.
To compare among the groups, we quantified the differences in
telomeric structures. Rg distribution frequency of individual
telomeres were represented by violin plots (Fig. 6h). Surprisingly,
the Rg mean of WT TRF1HP1α (90.7 nm) was significantly
higher than the mean Rgs of controls TRF1 (84 nm) and HP1α
(73.8 nm). The phenotype of the point mutant TRF1HP1α I165A
(Rg mean 83.6 nm) resembled that of the TRF1 control (84 nm).
We also noted that the Rg mean of TRF1 alone versus HP1α
alone differed. Further studies are underway to better understand
this phenomenon. We focused our analyses on the finding that
the Rg mean of WT TRF1HP1α was significantly higher than
both controls (TRF1 or HP1α) or point mutant TRF1HP1α
I165A. To quantify the proportions of irregular telomere
structures, mean Rg of TRF1 (84 nm) was applied as a reference
cut-off (Fig. 6h, dashed line). Fractions of telomeres with Rg equal
or greater than 84 nm were calculated (Fig. 6i). There was a
higher fraction of irregularly shaped telomeres in WT TRF1HP1α
(0.55) compared to TRF1 (0.44) or HP1α (0.27), and mutation
I165A reduced this back down to 0.43, similar to in TRF1 (0.44)
(Fig. 6i). Together, these data indicate that tethering WT HP1α at
telomeres results in increased irregularly shaped telomeres.
Discussion
The establishment of a dynamic telomeric chromatin is important
for the structural and functional integrity of telomeres.
However, how structural determinants impact telomere main-
tenance is largely unknown. We experimentally enhanced
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heterochromatinization at chromosomal ends by enriching HP1α
specifically at telomeres. The results reported here, summarized in
Fig. 7, provide insights into how heterochromatin alters telomere
maintenance and structure. Using TRF1 for telomere-tethering of
HP1α, which is detected naturally at telomeres but at low
occupancies14,33–35, we report that an intact dimerization domain
of HP1α, with its ligand binding function, is required to regulate
telomere extension. Thus, HP1α-induced chromatin alteration
can function as a gatekeeper of telomerase action. The require-
ment for ligand binding by HP1α suggests that this function
requires interaction with other factors. Moreover, employing
independent modes of inducing telomere damage (mutant DNA
repeat incorporation or shelterin TRF2 depletion), we find that
the tethered HP1α increases telomere protection. Future studies
will be of interest to determine if the telomere-localized chro-
matin changes induced by HP1α may also play an active role in
the DNA-damage responses themselves at the telomeres. Struc-
turally, we find that enhancing heterochromatin by tethering
HP1α increases the irregularity of telomere shapes, dependent on
an intact HP1α dimerization domain. This correlation suggests
the possibility that certain telomeric structural conformations
facilitate ligand binding efficiency to result in inhibition of telo-
mere extension by telomerase.
Previous reports, using in vitro nucleosome reconstitution
assays3,48, suggested TRF1 and TRF2 may play roles in both the
formation and dynamics of telomeric nucleosomal arrays. Telo-
meric DNA, like other chromosomal DNA, wraps around histone
protein cores, forming nucleosomes. We observed a slight
decrease of the core histone protein H3 occupancy at telomeres
by overexpressing just TRF1, and a further reduction upon
enriching HP1α at telomeres (Fig. 1). Decreased H3 at telomeres
might reflect displacement of some nucleosomes by the tethered
TRF1HP1α. This is consistent with the in vitro finding that tel-
omere sequence disfavors nucleosome assembly5.
TRF2, like TRF1, also directly binds double-stranded telomeric
DNA1,2. Interestingly however, our ChIP analysis found that
TRF1HP1α expression neither altered TRF2 occupancy (Fig. 1)
nor elevated TIFs (Fig. 4d–f), suggesting TRF1HP1α cohabited
with shelterin. We speculate that TRF1HP1αmay directly interact
with nucleosome-bound telomeric DNA in addition to
nucleosomal-free telomeric DNA without interfering with TRF2
binding. This is consistent with previous reports, using micro-
coccal nuclease I mapping in mouse embryonic fibroblasts,
showing no evident alteration of telomeric nucleosomal organi-
zation upon depletion of TRF2 or even the whole shelterin4,49. If
a significant amount of bulk TRF2 had been out-competed by
TRF1HP1α for telomere binding, we would have expected a
phenotype resembling that of overexpression of a dominant-
negative mutant (TRF2ΔBΔM)50, which was not observed. We
cannot exclude that the balance of other shelterin components
could be altered. These other components, including POT1,
TIN2, RAP1, and TPP1, bind to single-stranded telomeric DNA
and/or function as scaffold bridging proteins. Exactly how shel-
terins interplay with histones to regulate telomere dynamics are
important topics for future studies.
Through these studies, we uncovered and dissected some
specific functions of HP1α at telomeres. Telomerase plays a
crucial role in maintaining unlimited cellular proliferation in the
majority of cancer cells. Telomerase activity is regulated at mul-
tiple levels including transcriptional regulation51,52, holoenzyme
biogenesis53, trafficking and recruitment of telomerase to telo-
meres54. However, how local telomere chromatin dynamics reg-
ulate telomerase action and telomere length has been unclear.
Our HP1α mutational analyses suggest that the CSD region
functions as a negative regulator of telomerase action. The CSD is
required for HP1α dimerization and interaction with proteins
containing a conserved motif, PXVXL55. Candidates for such
ligands include shelterin component TIN256, and the telomere-
associated chromatin remodeler ATRX57, which both
contain PXVXL motifs. We speculate that their recruitment by
HP1α (directly or via another bridging complex) may impact
telomerase action, potentially through regulating telomerase
recruitment to the telomere58,59, polymerization initiation and/or
processivity60.
A main function of the CD region for HP1α is to recognize
H3K9me2/331. While WT TRF1HP1α enriched HP1α at telo-
meres, as expected some HP1α also localized to various other
genome regions, presumably harboring the recognition hetero-
chromatin marks (Fig. 3a–c). V22M mutant lacks the ability to
bind to heterochromatin marks at nontelomeric genomic regions,
and was exclusively tethered by TRF1 at the telomeres, and not to
other regions in the genome (Fig. 3b–d). Therefore, to exclude
potential confounding effects mediated via augmented binding to
such regions, we exploited mutant V22M intentionally as a
control, both to eliminate any tethering by TRF1HP1α of TRF1 at
nontelomeric sites, and to prevent indirect effects caused by
TRF1HP1α bound to genomic regions. Telomere-tethered HP1α-
directed inhibition of telomere extension was independent of
H3K9me2/3 recognition by the CD. Hence, H3K9m2/3 anchoring
is separable from inhibition of telomere extension.
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Here we have reported new connections between telomere
structure, protection and telomerase action (Table 1 and Fig. 7).
Overexpression of TRF1HP1α increased heterochromatin mark
H3K9me3 on telomeres, increased telomere protection, reduced
telomerase action and surprisingly induced irregular, often
visually extended, telomeric structures. Previous reports have
also suggested that silent chromatin was less condensed than
euchromatin since subtelomeric and pericentromeric hetero-
chromatin regions had lower protection in micrococcal nuclease
assays compared to the rest of the genome61. Despite the pre-
vailing assumption that highly condensed chromatin conforma-
tion is transcriptionally inert, transcription factors were found
to bind to heterochromatic repeat sequences across diverse
species62,63. Telomeres, while thought to be more heterochro-
matic than other genomic regions, are transcribed into telomere
repeat-containing RNA (TERRA)16 which interacts with TRF1
and TRF2 to regulate telomere length64. Although molecular
component changes at telomeres can trigger a switch from a
protected to a deprotected state65, our observed increased irre-
gularity of telomere shapes occur in the absence of DNA-damage
responses. We propose that these changes in telomere structures
can influence protection and telomerase action. It is also possible
that the reduced H3 at telomeres (Fig. 1) may influence nucleo-
some arrangements to result in a more irregular telomere
structure.
Telomere maintenance is crucial for cancer cell proliferation.
Telomere homeostasis is regulated at many different levels. Tel-
omere chromatin encompasses highly dynamic structures inter-
converting between different conformations. Thus, telomere
chromatin states may add another layer of protection to play
an important role in regulating chromosome end maintenance
and protection. Chromatin states are often altered during
tumorigenesis. It has become clear that, along with genomic
instability, epigenetic abnormalities promote carcinogenesis.
Heterochromatin-dependent, noncanonical telomere protection
strategies, resembling those found in flies or yeasts, may have
been selected for some human cancers. The possibility that some
cancers can adapt heterochromatin changes to stabilize their
telomeres will be interesting topics for future studies. Manip-
ulating the epigenetic status at telomeres should provide new
insights for the development of innovative telomere-directed,
epigenetic cancer therapeutics.
Methods
Cell culture. UM-UC3 (ATCC), U2OS (ATCC), BJ (ATCC), WI-38 (ATCC), and
lenti-X-293T (Clontech) cells were cultured at 37 °C in 5% CO2 in high glucose
DMEM medium (Hyclone, Logan, UT) containing 10% fetal bovine serum
(Hyclone, Logan, UT) and 1% (vol/vol) penicillin–streptomycin (Gibco).
Cotransfection was performed using PolyJet reagent (SignaGen Laboratories).
Plasmids and lentivirus. The pHR′ lentiviral plasmids were generated using the
second-generation lentiviral system provided by Dr. Didier Trono. HP1α was a gift
from Dr. Tom Misteli (Addgene plasmid # 17652)66. N-terminal EGFP-tagged
TRF1, HP1α, WT TRF1HP1α or mutants TRF1HP1α were subcloned into pHR′
respectively with HP1α (WT or various mutants) located on the C-terminus and
TRF1 in between EGFP and HP1α. HP1α mutants were gifts from Dr. Geeta
Narlikar36. Plasmids were driven by the CMV promoter followed by an internal
ribosome entry site and a blasticidin resistance gene. pHR′ mCherry-TRF2
expression lentiviral vector contained a hygromycin resistance gene. hTR expres-
sion lentiviral vectors driven by the IU1 promoter and a puromycin resistance gene
driven by the CMV promoter42,43. WT and mutant hTR template sequences were
as follows: WT—3′-CAAUCCCAAUC-5′; 47A—3′-CAAACCCAAAC-5′ and
TSQ1—3′-CCAACGCCAAC-5′. SgRNA targeting telomere (5′-caccgGTTAG
GGTTAGGGTTAGGGTTA) or Gal4 (5′-caccgGAACGACTAGTTAGGC
GTGTA) sequences were cloned into LentiCRISPRv2, a gift from Feng Zhang
(Addgene Plasmid #52961)67. Lentivirus was packaged in lenti-X-293T (Clontech)
using PolyJet reagent (SignaGen Laboratories). Drug selection was initiated 48 h
post infection with 50 µg/ml blasticidin for 5 days (ThermoFisher Scientific). For
introduction of a second round of infection with either WT or mutant hTRs, cells
were selected using 8 µg/ml puromycin for 1 day (ThermoFisher Scientific).
Western blotting. Cells were lysed [10 mM Tris-HCl pH 7.4, 150 mM NaCl, 0.5%
IGEPAL CA-630, 10% glycerol, 1 mM EDTA, 1× Halt protease inhibitor cocktail
(ThermoFisher Scientific), 1 mM DTT, Benzonase nuclease 50 U/ml (Novagen)].
Lysate was spun at 13,000 rpm (15 min at 4 °C). Supernatant was heated at 95 °C
for 5 min. Protein concentration was measured using Precision Red protein assay
reagent (Cytoskeleton, Inc.). ~40 µg lysates were separated by SDS-PAGE and
transferred onto the Immobilon P PVDF membrane (EMD Millipore). The blots
were then blocked for 30 min at room temperature with 5% milk in TBST (20 mM
Tris pH 7.4, 150 mM NaCl, 0.05% Tween 20) and incubated for 1 h each at room
temperature with primary antibodies followed by secondary horseradish
peroxidase-conjugated antibodies. After washing, the blots were treated with che-
miluminescent reagents (SuperSignal West Pico kit, ThermoFisher) and exposed to
films. Primary antibodies used include 1:5000 rabbit anti-GFP (A11122; Invitro-
gen); 1:1000 rabbit anti-TRF1 (ab1423; Abcam); 1:2000 goat anti-HP1α (ab77256;
Abcam); 1:2000 goat anti-TRF2 (NB110-57130), 1:1000 mouse anti-Cas9 (A-9000;
Epigentek), 1:200 mouse anti-p53 (sc-126; Santa Cruz), and 1:1000 mouse anti-
GAPDH (MA515738; ThermoFisher). Secondary antibodies used include 1:5000
Goat Anti-Mouse IgG-HRP (115-035-166; Jackson ImmunoResearch), 1:5000 Goat
Anti-Rabbit IgG-HRP (111-035-144; Jackson ImmunoResearch), 1:5000 Donkey
Anti-Goat IgG-HRP (sc2020; Santa Cruz Biotechnology). Uncropped blots are
shown in Supplementary Fig. 9.
Chromatin immunoprecipitation and dot blot assays. 20×106 cells were tryp-
sinized and crosslinked with 1% paraformaldehyde (w/v) (ThermoFisher Scientific)
at room temperature for 5 min, followed by 125 mM glycine (Sigma) for 5 min to
quench the crosslinking and washed (cold 1× PBS, 1 mM PMSF). All subsequent
steps were performed at 4 °C, unless noted otherwise. Cells were resuspended into
ChIP lysis buffer (0.5% NP-40, 85 mM KCl, 20 mM Tris-HCl pH 8.0 with 1× Halt
protease inhibitor cocktail (ThermoFisher Scientific)) for 15 min, homogenized
with a pellet pestle (ThermoFisher Scientific), and spun at 450 x g for 5 min. Nuclei
pellets were incubated in nuclear lysis buffer (1% SDS, 50 mM Tris-HCl pH 8.0,
10 mM EDTA with 1× Halt protease inhibitor cocktail) for 30 min, further lysed
with a syringe, and sonicated with Covaris S2 to obtain fragments between 400 and
1000 base pairs. Fragment sizes were checked by running an aliquot of the sheared,
purified chromatin on an agarose gel. Sheared chromatin was spun at 13,000 rpm
for 10 min, and supernatant (2×106 cells/reaction) was incubated overnight with
10 μg of ChIP-grade antibodies respectively: anti-H3 (ab1791; Abcam); anti-HP1α
(ab77256; Abcam); anti-H3K9me3 (ab8898; Abcam), anti-TRF2 (NB110-57130;
Novus Biologicals); anti-TRF1 (ab1423; Abcam,) and anti-rabbit IgG (#2729; Cell
Signaling). Samples were then immunoprecipitated with Dynabeads Protein G (Life
Technologies) for >6 h to overnight, washed and eluted (1× TE, 1% SDS, 250 mM
NaCl). Immunoprecipitated chromatin was treated with 0.2 µg/µl RNAse at 37 °C
for 30 min, followed by reverse crosslinking (0.2 µg/µl Proteinase K (Bioline) and
200 mM NaCl) at 65 °C for >6 h to overnight. DNA was purified using NucleoSpin
Gel and PCR cleanup kit (Macherey-Nagel), denatured (0.1 M NaOH) at 37 °C for
30 min, neutralized (6× SSC), and transferred to a Hybond-N+ membrane
(Amersham) on a dot blot.
24 nt C-strand telomeric probes containing six 32P-dC were synthesized68. One
microliter annealed template C-rich oligo (1.7 pmol/μl), 1 μl of dTTP (1.25 mM
Table 1 Summary of experimental data describing impact of WT versus mutants TRF1HP1α on telomere lengthening and TIF
(via 47A or TRF2 depletion)
Baseline TRF1HP1α
WT V22M I165A W174A NS2A KRKAAA
Telomere lengthening +++ + + +++ ++ + +
TIF via 47A +++ + + +++ ++ ++ ++
TIF via si-TRF2 +++ + + +++ ++ + +
+++ (strong telomere lengthening, high number of TIF), ++ (intermediate phenotype), + (weak telomere lengthening, low number of TIF)
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stock, final 50 μM), 7 μl 32P-dCTP (3000 Ci/mmol), 4 μl 32P-dATP (3000 Ci/
mmol), 7.9 μl Millipore H2O, and 1 μl Klenow (5 U/μl) were combined in a final
volume of 25 μl. Room temperature extension was carried out for 30 min, and
95 °C for 5 min [to inactivate Klenow to prevent probe degradation upon uracil
deglycosylase (UDG) treatment]. The reaction was cooled to room temperature.
0.5 μl UDG (1 U/μl) was added to degrade the GTU template, incubated at 37 °C
for 15 min, and then UDG was inactivated at 95 °C for 10 min. Free isotopes were
removed using an illustra microspin G-25 column (GE Healthcare, Piscataway, NJ).
CENPB (5′-CTTCGTTGGAAACGGGA-3') probes were end-labeled with [γ-32P]
ATP. Half of the blot was hybridized with C-strand telomeric probes, and the other
half with CENPB probe at 42 °C overnight. The blots were then washed and
exposed to a Phosphorimager screen (GE Healthcare). Uncropped dot blots are
shown in Supplementary Fig. 1.
Telomere restriction fragment length analysis. Genomic DNA was purified
using DNeasy Blood & Tissue kit (Qiagen, Valencia, CA). Telomere Restriction
Fragment (TRF) length analysis was performed69. 1 µg purified genomic DNA was
digested in 20 μl reaction with Alu, MspI, HaeIII, HinfI, HhaI and RsaI for 4 h at
37 °C. DNA was separated on a 0.8% agarose gel in 0.5× TBE. The gel was dried,
denatured (0.5 M NaOH and 1.5 M NaCl for 1 h), rinsed with distilled water (3×),
neutralized (0.5 M Tris-HCl pH8 and 1.5 M NaCl for 30 min), prehybridized (6×
SSC, 5× Denhardt’s solution, 0.5% (w/v) SDS), and hybridized with C-strand
telomeric probe at 42 °C overnight. The gel was then washed and exposed to a
Phosphorimager screen (GE Healthcare). Average overhang sizes were calculated
using the formula mean average length= ∑(Inti) / ∑(Inti / MWi), where Inti= sig-
nal intensity and MWi=molecular weight of the DNA at position i69.
DNA in Supplementary Fig. 6a and 6i were digested with RsaI and HinfI.
Generally size markers were loaded on TRF gels. However, the DNAs in
Supplementary Fig. 6a and 6i were only run for a very short time so that the
telomeres would remain as compact as possible to maximize the ability to detect
remaining telomere resulting from Cas9-digestion. As size markers would not have
been able to be resolved during this short run, they were eliminated in this in-gel
hybridization. Here we focused on quantifying telomeric intensity using Alu probe
(5′-CACGCCTGTAATCCCAGCACTTTG-3') end-labeled with [γ-32P] ATP as
loading controls. Gels were denaturized and neutralized between C-strand telomere
probe and Alu probe hybridization. Uncropped gels are shown in Supplementary
Fig. 10.
Beta-galactosidase assay. Senescence-associated beta-galactosidase (β-gal) was
analyzed using colorimetric β-gal staining kit (Cell Signaling) or quantified by
fluorometric kit (Cell Biolabs). Total protein was measured using Precision Red
protein assay reagent (Cytoskeleton, Inc.).
Cell growth assays. Cells were infected with either WT or mutant hTRs at day 0,
and selected with puromycin at day 2. Cells were split as needed to maintain
logarithmic growth, and harvested at indicated time points and stained with trypan
blue. Viable cells were scored by TC20 automatic cell counter (Bio-Rad).
Telomere dysfunction-induced foci (TIF) image analysis. Cells were washed
with 1× PBS, fixed with 4% paraformaldehyde (w/v) (ThermoFisher) in 1× PBS
and permeabilized with 0.5% NP-40 for 15 min. IF/FISH42 was performed with
modifications. For IF, cells were blocked (0.2% (w/v) fish gelatin, 0.5% (w/v) BSA in
PBS for 20 min), and immunostained with the primary antibody pAb anti-53BP1
(NB100-304; Novus Biologicals) 1:500 for 1 h. Cells were then washed and incu-
bated with secondary antibody Alexa Fluor 488 (Molecular Probes) 1:750 for 1 h,
fixed with 2% paraformaldehyde and incubated with 0.1 mg/ml RNAse for 1 h at
37 °C. For, FISH, cells were dehydrated sequentially with ethanol (70%, 95% and
100%; 5 min each), heated in hybridization mix with 0.5 mg/ml peptide nucleic
acid (PNA) telomeric probe TelC-Cy3 (PNABio) at 85 °C for 10 min to denature
the DNA, followed by overnight hybridization at room temperature. Nuclei were
stained with DAPI (4,6-diamidino-2-phenylindole) (Life Technologies) and
mounted with Prolong Gold (Invitrogen).
Equipment and settings: Images were captured using a DeltaVision Real-time
Deconvolution Microscope (Applied Precision) with a ×100 oil 1.4 NA Plan Apo
objective (Olympus) by a Photometrics CoolSNAP HQ monochrome CCD camera.
0.25 µm increments (×20 stacks for a total of 5 µm) were deconvoluted and Z-
projected in SoftWoRx (Applied Precision).
TIFs colocalization analysis: Z-Projected images were converted to Tagged
Image File Format (TIFF) using the Fiji image processing package (www.fiji.sc).
Enumeration of 53BP1 and telomeric foci were quantified using CellProfiler 2.1.1.
(www.cellprofiler.org) image analysis software. For foci scoring, identical
thresholds were applied to all controls and experimental groups, followed by
colocalization (TIFs) masking (pipelines available on request).
TRF2 knockdown. Cells were transfected with ON-target plus smart pool con-
sisting TRF2 (siRNA) or si-non-targeting (Dharmacon) using Lipofectamine
RNAiMAX reagent (Life Technologies) following manufacture protocols, and
analyzed at ~72 h.
STORM image acquisition and analysis. STORM equipment and settings:
STORM70 was performed on a custom-built microscope based on a Nikon Ti-U
inverted microscope. Three activation imaging lasers (Coherent CUBE 405,
OBIS 561 and CUBE 642) were combined using dichroic mirrors, aligned,
expanded and focused to the back focal plane of the objective (Nikon Plan Apo
×100 oil NA 1.45). The lasers were controlled directly by the computer. A quad
band dichroic mirror (zt405/488/561/640rpc, Chroma) and a band-pass filter
(ET705/70m, Chroma) separated the fluorescence emission from the excitation
light. During image acquisition, the focusing of the sample was stabilized by a
closed-loop system that monitored the back reflection from the sample cover-
glass via an infrared laser beam sent through the edge of the microscope
objective.
A low-end piezoelectric deformable mirror (DM) (DMP40-P01, Thorlabs) was
added in the emission path at the conjugate plane of the objective pupil plane70. By
first flattening the mirror and then manually adjusting key Zernike polynomials,
this DM corrected aberrations induced by both the optical system and the glass-
water refractive index mismatch when the sample was several micrometers away
from the coverglass. After correcting these aberrations, an astigmatic aberration
was further added by the DM for 3D STORM. The fluorescence was recorded at a
frame rate of 57 Hz on an electron multiplying CCD camera (Ixon+ DU897E-CS0-
BV, Andor).
The mounting medium used for STORM imaging was PBS with the addition of
100 mM mercaptoethylamine at pH 8.5, 5% glucose (w/v) and oxygen scavenging
enzymes 0.5 mg/ml glucose oxidase (Sigma-Aldrich), and 40 mg/ml catalase (Roche
Applied Science). The buffer remained suitable for imaging for 1–2 h. Photo-
switchable dye Cy5 was used for imaging with a ratio of one dye per PNA probe.
Cy5 was excited with a 642 nm imaging laser, with a typical power at the back port
of the microscope being 30 mW. Analysis of STORM raw data was performed in
the Insight3 software47, which identified and fitted single molecule spots in each
camera frame to determine their x, y, and z coordinates as well as photon numbers.
Sample drift during data acquisition was corrected using imaging correlation
analysis. The drift-corrected coordinates, photon number, and the frame of
appearance of each identified molecule were saved in a molecule list for further
analysis.
STORM imaging: Cells were labeled with PNA telomeric probe, TelC-Cy5
(PNABio). Individual telomeric localization signals were detected by switching the
fluorophores between active and dark states stochastically. Accumulation of
individual fluorophore forms a cluster of molecular positions, known as
localizations, corresponding to structural characteristics of an individual telomere.
STORM analysis: Individual telomeres were manually selected from
the STORM images. The telomeres near focal planes with good resolution
were picked. These manually picked telomeres were further screened so that
telomeres with more than 200 localizations were kept for the Radius of gyration
(Rg) analysis.
Statistical analyses. Significance of mean was assessed by statistical analyses
noted in the corresponding figure legends. These include: one-way ANOVA and
Dunnett’s multiple comparison test with 95% confidence level; two-tailed unpaired
t test with 95% confidence level. All graph bars were represented by means with
standard error of the mean (s.e.m.). For STORM statistical analysis, means of Rg in
the violin plots were compared using ANOVA Tukey’s multiple comparisons with
95% confidence level.
Code availability. Custom image analysis for Rg calculation were written in
MATLAB 2012B. The MATLAB script is available from the authors upon request.
Data availability
All relevant data and supplementary information files are included in this published
article. All other supporting information is available from the authors upon reasonable
request.
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